Literature DB >> 20979478

Products at risk.

Gregory D Curfman, Stephen Morrissey, Jeffrey M Drazen.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20979478     DOI： 10.1056/NEJMe1010348

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials.

Authors:  Janet T Holbrook; John H Kempen; Nancy A Prusakowski; Michael M Altaweel; Douglas A Jabs
Journal:  Clin Trials       Date:  2011-10-12       Impact factor: 2.486

2.  NHLBI ASTHMA NETWORKS: IMPROVING PATIENT CARE, MOVING TOWARD PERSONALIZED MEDICINE.

Authors:  Stephen P Peters
Journal:  Trans Am Clin Climatol Assoc       Date:  2022

Review 3.  An early indicator of drug success: Top Journal Selectivity Index.

Authors:  Igor Kissin
Journal:  Drug Des Devel Ther       Date:  2013-02-13       Impact factor: 4.162

4.  Blinding in pharmacological trials: the devil is in the details.

Authors:  Mandy Wan; Mine Orlu-Gul; Helene Legay; Catherine Tuleu
Journal:  Arch Dis Child       Date:  2013-07-29       Impact factor: 3.791
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.